Genetic Control of Glutamate Receptor Function
Genetic Control of Glutamate Receptor Function
批准号:
7341062
负责人:
RAYMOND J DINGLEDINE
金额:
$33.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 2010-11-30
关键词:
3&apos Untranslated Regions5&apos Untranslated RegionsAMPA ReceptorsAddressAdultAgonistAntibodiesBrainCalciumChromatin StructureComplexCordycepinDataDendritic SpinesDominant-Negative MutationDown-RegulationElementsExcitatory SynapseGenesGeneticGluR2 subunit AMPA receptorGlutamate ReceptorInternal Ribosome Entry SiteInterneuronsIschemiaLasersLearningLigationMAP Kinase GeneMAP Kinase Signaling PathwaysMediatingMessenger RNAMitogen-Activated Protein KinasesN-Methyl-D-Aspartate ReceptorsNeuraxisNeuronsOocytesPathway interactionsPhasePhenotypePhysiologicalPolyadenylationPolymerase Chain ReactionPopulationPropertyProtein BiosynthesisProtein OverexpressionProteinsRNARateReceptor GeneRegulationRegulatory ElementRelative (related person)ReporterRepressionResponse ElementsSeizuresSignal TransductionSiteStimulusStructureSynapsesSynaptic ReceptorsSynaptic plasticitySystemTestingTranscriptTransgenic MiceTranslatingTranslational RegulationTranslationsUntranslated RegionsWorkXenopus oocytealpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acidamino 3 hydroxy 5 methylisoxazole 4 propionatebasecell injurygenetic manipulationmutantpostsynapticpromoterreceptorreceptor functionresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The abundance of GluR2 mRNA relative to other AMPA receptor subunit mRNAs is highly variable in many GABAergic interneurons, which endows them with a wide spectrum of AMPA receptor properties. GluR2 mRNA and protein levels decline following intense seizure activity or transient ischemia in certain vulnerable neuron populations before clear histological signs of cell damage, raising the possibility that larger synaptic currents or excess calcium entry through newly synthesized GluR2-deficient AMPA synaptic receptors contributes to the later phase of neuron damage. There is evidence for activity-dependent local dendritic translation of GluR2 mRNA, and for postsynaptic GluR2 translation following LTP stimuli. All of these findings indicate that the mechanisms responsible for moderate changes in GluR2 expression - developmentally, during synaptic plasticity, and after seizures or traumatic insult in the adult - are important neuronal regulatory controls governing synaptic phenotype. Work in the current project period has identified specific transcriptional and translational regulatory mechanisms operating on AMPA receptor genes. In the proposed work we intend to test the following hypotheses: i) that translational regulation of GluR2 mRNA requires one or more of the multiple conserved cytoplasmic polyadenylation elements (CPE) or polyadenylation response elements (PRE) resident in the 3'UTR; ii) that MAP kinase pathways exert dual control over translation of GluR2 transcripts; iii) that neuron-dependent transcriptional start site selection influences the form and extent of translational control by 5' and 3'UTR; and iv) that repression of GluR2 expression by seizures requires the RE1 silencer in the GluR2 promoter. Regulation of the physiological properties of glutamate receptor channels at the translational and transcriptional levels should be relevant to the late phase of LTP, learning, and the response to seizures, as well as other situations in which receptor phenotype is remodeled .
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/j.1471-4159.2009.05992.x
发表时间:
2009-04
期刊:
Journal of neurochemistry
影响因子:
4.7
作者:
[Irier HA, Shaw R, Lau A, Feng Y, Dingledine R]
通讯作者:
Dingledine R
Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitro.
大鼠新皮质细胞在体内和分离的神经末端在体外对果糖的摄取和代谢。
DOI:
10.1111/jnc.13079
发表时间:
2015-05
期刊:
Journal of neurochemistry
影响因子:
4.7
作者:
[Hassel B, Elsais A, Frøland AS, Taubøll E, Gjerstad L, Quan Y, Dingledine R, Rise F]
通讯作者:
Rise F
Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.
对映体丙醇胺作为选择性 N-甲基-D-天冬氨酸 2B 受体拮抗剂。
DOI:
10.1021/jm8002153
发表时间:
2008
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Tahirovic,YesimA, Geballe,Matthew, Gruszecka-Kowalik,Ewa, Myers,ScottJ, Lyuboslavsky,Polina, Le,Phuong, French,Adam, Irier,Hasan, Choi,Woo-Baeg, Easterling,Keith, Yuan,Hongjie, Wilson,LawrenceJ, Kotloski,Robert, McNamara,JamesO, Dingledi]
通讯作者:
Dingledi
Subunit-dependent modulation of kainate receptors by muscarinic acetylcholine receptors.
毒蕈碱乙酰胆碱受体对红藻氨酸受体的亚基依赖性调节。
DOI:
10.1016/j.brainres.2010.07.029
发表时间:
2010
期刊:
Brain research
影响因子:
2.9
作者:
[Benveniste,Morris, Wilhelm,Jennifer, Dingledine,RaymondJ, Mott,DavidD]
通讯作者:
Mott,DavidD
DOI:
10.1016/j.bmc.2009.05.085
发表时间:
2009-09-01
期刊:
BIOORGANIC & MEDICINAL CHEMISTRY
影响因子:
3.5
作者:
[Mosley, Cara A., Myers, Scott J., Murray, Ernest E., Santangelo, Rose, Tahirovic, Yesim A., Kurtkaya, Natalie, Mullasseril, Praseeda, Yuan, Hongjie, Lyuboslavsky, Polina, Le, Phuong, Wilson, Lawrence J., Yepes, Manuel, Dingledine, Ray, Traynelis, Stephen F., Liotta, Dennis C.]
通讯作者:
Liotta, Dennis C.
共 6 条
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
-
批准号:10467539
-
项目类别:
-
资助金额:$67.75万
-
财政年份:2022
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
-
批准号:10732636
-
项目类别:
-
资助金额:$67.95万
-
财政年份:2022
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
-
批准号:10356163
-
项目类别:
-
资助金额:$52.02万
-
财政年份:2020
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
-
批准号:10171930
-
项目类别:
-
资助金额:$52.02万
-
财政年份:2020
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
-
批准号:10570244
-
项目类别:
-
资助金额:$52.02万
-
财政年份:2020
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Probing the Protective Role of EZH2 in Epilepsy
-
批准号:10617699
-
项目类别:
-
资助金额:$50.7万
-
财政年份:2019
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Probing the Protective Role of EZH2 in Epilepsy
-
批准号:10398140
-
项目类别:
-
资助金额:$50.7万
-
财政年份:2019
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures
-
批准号:9272954
-
项目类别:
-
资助金额:$42.75万
-
财政年份:2016
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures
-
批准号:9914359
-
项目类别:
-
资助金额:$42.22万
-
财政年份:2016
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures
-
批准号:9159612
-
项目类别:
-
资助金额:$44.45万
-
财政年份:2016
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Regulation of epileptogenesis by the transcriptional repressor, REST
-
批准号:8325008
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2011
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Regulation of epileptogenesis by the transcriptional repressor REST
-
批准号:8711572
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2011
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Role of COX2 of Neuronal Origin in Blood-Brain Communication after status epilept
-
批准号:8243393
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2011
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
EP2 Allosteric Potentiators for Subarachnoid Hemorrhage
-
批准号:8128268
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2011
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Regulation of epileptogenesis by the transcriptional repressor, REST
-
批准号:8220003
-
项目类别:
-
资助金额:$35.2万
-
财政年份:2011
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
EP2 Allosteric Potentiators for Subarachnoid Hemorrhage
-
批准号:8284308
-
项目类别:
-
资助金额:$3.19万
-
财政年份:2011
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Role of COX2 of Neuronal Origin in Blood-Brain Communication after status epilept
-
批准号:8319322
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2011
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Regulation of epileptogenesis by the transcriptional repressor, REST
-
批准号:8522323
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2011
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Faculty Recruitment in Novel Therapeutic Strategies for Neurodegenerative Disease
-
批准号:7933981
-
项目类别:
-
资助金额:$74.75万
-
财政年份:2009
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
Faculty Recruitment in Novel Therapeutic Strategies for Neurodegenerative Disease
-
批准号:7858933
-
项目类别:
-
资助金额:$63.75万
-
财政年份:2009
-
负责人:RAYMOND J DINGLEDINE
-
依托单位:
海外基金